P2X7受体特异性放射性配体18F-FTTM用于动脉粥样硬化斑块PET显像
本研究基于铜介导的芳基锡烷放射性氟化合成P2X7靶向示踪剂18F-FTTM,在ApoE-/-小鼠(高脂饮食10、20、30周)与野生型C57BL/6 J小鼠中行Micro-PET/CT显像。结果显示随疾病进展体内外显像信号增加且与组织病理学特征相关;高脂喂养20周和30周ApoE-/-小鼠主动脉弓SUVmax分别较对照组高43%和53%。
要点
- 18F-FTTM放射化学产率5-10%、比活度269-320 MBq/nmol、放射化学纯度>99%。
- 随疾病进展体内外显像信号增加,并与组织病理学特征相关。
- 高脂喂养20和30周ApoE-/-小鼠主动脉弓SUVmax较对照组分别高43%和53%。
核心结论
- 作者创新性地应用新型P2X7靶向PET探针18F-FTTM识别易损动脉粥样硬化斑块、检测动脉粥样硬化的炎症反应,为动脉粥样硬化病变诊断和精准治疗的新药筛选提供有力的无创方法。
研究设计与样本
- 基于铜介导的芳基锡烷放射性氟化合成放射性配体18F-FTTM,并行体外与体内实验验证其生化性质。
- 对高脂饮食10、20、30周的ApoE-/-小鼠与正常饮食的野生型C57BL/6 J小鼠行1小时动态18F-FTTM Micro-PET/CT显像。
- 行离体PET显像验证放射性配体的特异性;用ELISA检测血清炎症细胞因子、血脂和脂蛋白谱。
- 用油红O、HE、Masson和免疫荧光染色评估斑块脂质分布与形态。
主要发现
- 18F-FTTM的衰变校正放射化学产率为5-10%,比活度为269-320 MBq/nmol(n=8,EOS),放射化学纯度高于99%。
- 18F-FTTM体外稳定性优良,在小鼠体内血液清除快,对RAW264.7细胞有良好亲和力。
- 随疾病进展,体内和离体显像信号均增加,且显像特征与组织病理学特征相关。
- 与18F-FDG显像相比,高脂喂养20周和30周ApoE-/-小鼠主动脉弓的18F-FTTM SUVmax分别较对照组高43%和53%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: P2X7 receptors have been considered as a promising biomarker for vulnerable atherosclerotic plaques, which are highly expressed by that instability-associated factors such as macrophages. Thus, we aim to investigate the feasibility of using specific P2X7-targeted 18F-labeled tracer 18F-FTTM ((2-chloro-3-[18F]fluorophenyl)[1,4,6,7-tetrahydro-1-(2-pyrimidinyl)-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl]methanone) for PET study of vulnerable atherosclerotic plaques identification. METHOD: The radioligand 18F-FTTM was achieved based on the copper-mediated radiofluorination of arylstannane. In vitro and in vivo experiments were performed to verify the biochemical properties. Dynamic 18F-FTTM Micro-PET/CT imaging was performed for 1 h on ApoE-/- mice (10, 20, 30 weeks on high-fat diet) and wild-type C57BL/6 J mice on normal diet. Ex vivo PET imaging was conducted to verify the specificity of the radioligand. Serum inflammatory cytokines, lipids, and lipoproteins profiles were detected by ELISA. The lipid distribution and morphology of plaques were evaluated by Oil Red O, HE, Masson, and immunofluorescence stainings. RESULTS: 18F-FTTM was afforded with decay-corrected radiochemical yields of 5-10%, specific activity of 269-320 MBq/nmol (n = 8, EOS), and radiochemical purity of above 99%. 18F-FTTM showed excellent stability in vitro, rapid blood clearance in mice, good affinity to RAW264.7 cells. We observed an increase in both in vivo and ex vivo imagings as disease progressed, and the imaging signatures correlated with histopathological features. Furthermore, compared with 18F-FDG imaging, the SUVmax values of 18F-FTTM at the aortic arch of ApoE-/- mice of high-fat feeding for 20 and 30 weeks were 43% and 53% higher than those of the control group, respectively. CONCLUSION: We innovatively apply a new type P2X7-targeted PET probe (18F-FTTM) to identify vulnerable atherosclerotic plaques, to detect the inflammatory response of atherosclerosis, and to provide a powerful non-invasive method for the diagnosis of atherosclerotic lesions and new drug screening for accurate treatment.
引用
- Fu Z, Lin Q, Xu Z, et al. P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging. Eur J Nucl Med Mol Imaging. 2022. PMID: 35048153. doi:10.1007/s00259-022-05689-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。